Fibrinopeptide B, human is a compound released from fibrinogen by thrombin action. Release of fibrinopeptide B from fibrinogen appears to be necessary for Ca2+ uptake and subsequent binding to fibrin.
CAT No: 10-101-290
CAS No:36204-23-6
Synonyms/Alias:Fibrinopeptide B;36204-23-6;Fibrinopeptide B, human;Fibrinopeptide B (human);FPB,human;Fibrinopeptides B;Fibrinopeptide B (human) acetate salt;Fibrinopeptide B human;DA-73358;
Fibrinopeptide B, human, is a specialized peptide fragment derived from the N-terminal region of the human fibrinogen beta chain. This synthetic peptide is released during the enzymatic cleavage of fibrinogen by thrombin, a critical step in the coagulation cascade. As a highly conserved biomolecule, Fibrinopeptide B plays a pivotal role in the transition from soluble fibrinogen to insoluble fibrin, marking the initiation of blood clot formation. Its unique sequence and structural properties make it a valuable tool for researchers exploring the molecular mechanisms of hemostasis, thrombosis, and related physiological processes. Fibrinopeptide B, human, is widely recognized for its utility in basic and applied research, serving as a reference standard, substrate, and analytical target in diverse scientific investigations.
Coagulation Pathway Research: Fibrinopeptide B, human, is extensively employed in studies aimed at elucidating the intricate processes underlying blood coagulation. By serving as a model substrate for thrombin activity, it enables researchers to monitor the enzymatic conversion of fibrinogen to fibrin, facilitating the characterization of key regulatory steps within the coagulation cascade. Its use in in vitro assays allows for precise quantification of thrombin generation and activity, providing insights into the dynamics of clot formation and the interplay between coagulation factors. This application is particularly valuable for dissecting the molecular events that govern hemostatic balance and for identifying novel targets for anticoagulant development.
Thrombosis Mechanism Studies: In investigations focused on thrombosis, Fibrinopeptide B serves as a critical biomarker and mechanistic probe. Its release from fibrinogen during clot formation can be quantitatively measured in plasma samples, providing a direct indicator of thrombin activity and ongoing coagulation events. By monitoring the levels of this peptide, researchers can assess the extent and kinetics of thrombus development in various experimental models. Such studies contribute to a deeper understanding of pathological clotting, support the evaluation of antithrombotic agents, and aid in the identification of risk factors associated with hypercoagulable states.
Proteomics and Mass Spectrometry: Fibrinopeptide B, human, is a widely used reference peptide in proteomic analyses, particularly in mass spectrometry-based quantification. Its well-characterized sequence and predictable fragmentation patterns make it an ideal internal standard for calibrating instruments and validating peptide identification workflows. In complex biological samples, the detection and quantification of this peptide enable accurate assessment of fibrinogen cleavage and thrombin activity. The use of Fibrinopeptide B as a proteomic marker enhances the reliability and reproducibility of analytical results, supporting biomarker discovery and the study of coagulation-related pathologies.
Immunoassay Development: Fibrinopeptide B is frequently utilized in the development and optimization of immunoassays designed to detect and quantify fibrinogen degradation products. By serving as a target antigen or calibrator, it facilitates the generation of highly specific antibodies and the establishment of sensitive assay platforms. These immunoassays are instrumental in research settings for monitoring coagulation status, evaluating the efficacy of anticoagulant interventions, and investigating the molecular signatures of clot formation. The versatility of Fibrinopeptide B in immunoassay development underscores its significance in advancing diagnostic and research methodologies.
Cell Signaling and Chemotaxis Research: Beyond its established roles in coagulation, Fibrinopeptide B, human, has been implicated in modulating cellular responses such as chemotaxis and inflammation. Studies have demonstrated that this peptide can act as a signaling molecule, influencing the migration and activation of various cell types, including leukocytes. By incorporating Fibrinopeptide B into in vitro cell culture and migration assays, researchers can dissect its impact on cellular behavior, elucidate receptor-mediated signaling pathways, and explore its potential involvement in immune responses and tissue repair. This application highlights the expanding research interest in the extracoagulant functions of Fibrinopeptide B and its relevance to broader physiological and pathological contexts.
2. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
3. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
4. The spatiotemporal control of signalling and trafficking of the GLP-1R
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More